HUNTINGTON DISEASE
Clinical trials for HUNTINGTON DISEASE explained in plain language.
Never miss a new study
Get alerted when new HUNTINGTON DISEASE trials appear
Sign up with your email to follow new studies for HUNTINGTON DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental Huntington's drug shows promise in small safety study
Disease control CompletedThis early-stage study tested an experimental drug called ER2001 in 8 adults with early Huntington's disease. The main goal was to check if the drug is safe and how the body processes it. Participants received increasing doses of the drug through an IV over 6 weeks. This study is…
Matched conditions: HUNTINGTON DISEASE
Phase: EARLY_PHASE1 • Sponsor: ExoRNA Bioscience • Aim: Disease control
Last updated May 26, 2026 02:59 UTC
-
Stem cells take on Huntington's: new trial shows promise
Disease control CompletedThis study tested a stem-cell treatment called Cellavita HD in 49 adults with Huntington's disease. Participants received one of two doses or a placebo, and researchers tracked changes in motor skills over time. The goal was to see if the therapy could slow down the worsening of …
Matched conditions: HUNTINGTON DISEASE
Phase: PHASE2 • Sponsor: Azidus Brasil • Aim: Disease control
Last updated May 26, 2026 02:53 UTC
-
Diabetes drug metformin tested as brain booster for Huntington's patients
Disease control CompletedThis study tested whether metformin, a common diabetes medicine, could help slow down thinking and memory problems in people with Huntington's disease. Sixty adults with Huntington's took either metformin or a placebo pill every day for a year. The goal was to see if metformin co…
Matched conditions: HUNTINGTON DISEASE
Phase: PHASE3 • Sponsor: Instituto de Investigacion Sanitaria La Fe • Aim: Disease control
Last updated May 26, 2026 02:51 UTC
-
New Huntington's drug shows promise in small safety study
Disease control CompletedThis early study tested a new drug, ER2001, in 10 adults with early Huntington's disease. The main goal was to check if the drug is safe and how the body processes it. Researchers also looked for early signs that the drug might help control the disease.
Matched conditions: HUNTINGTON DISEASE
Phase: EARLY_PHASE1 • Sponsor: ExoRNA Bioscience • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
New Huntington's drug shows promise in Mid-Stage trial
Disease control CompletedThis study tested an experimental drug called PTC518 in 159 adults with Huntington's disease. The main goal was to check the drug's safety and how it affects a key protein linked to the disease. Researchers also looked at brain scans and movement scores to see if the drug might s…
Matched conditions: HUNTINGTON DISEASE
Phase: PHASE2 • Sponsor: PTC Therapeutics • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
New drug shows promise for brain function in Huntington's patients
Disease control CompletedThis study tested a drug called SAGE-718 in 69 people with early Huntington's disease to see if it could improve thinking and daily functioning. Participants took the drug or a placebo for 28 days. The main goal was to measure changes in cognitive abilities like memory and proble…
Matched conditions: HUNTINGTON DISEASE
Phase: PHASE2 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 18, 2026 12:08 UTC
-
Dance classes show promise for Huntington's patients and families
Symptom relief CompletedThis study looked at whether taking weekly dance classes for 8 months can help people with Huntington's disease improve their movement, sense of control, and quality of life. Researchers also studied how dance affects the patients' partners and caregivers. The goal was to see if …
Matched conditions: HUNTINGTON DISEASE
Phase: NA • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Symptom relief
Last updated May 26, 2026 02:58 UTC
-
Virtual reality brain training takes on music therapy for Parkinson's and Huntington's patients
Symptom relief CompletedThis study tested whether cognitive rehabilitation using immersive virtual reality or computer-based brain games could improve mild thinking problems in people with Parkinson's or Huntington's disease better than music therapy. 64 participants completed the trial, which compared …
Matched conditions: HUNTINGTON DISEASE
Phase: NA • Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau • Aim: Symptom relief
Last updated May 26, 2026 02:52 UTC
-
Drumming away symptoms: music therapy shows promise for Parkinson's and Huntington's
Symptom relief CompletedThis study looked at whether group drum classes could help people with Parkinson's or Huntington's disease feel better and move easier. Eighteen adults aged 18-89 took drum lessons twice a week for 12 weeks. Researchers checked their hand movement, mood, and overall well-being be…
Matched conditions: HUNTINGTON DISEASE
Phase: NA • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated May 01, 2026 15:58 UTC
-
Coffee's effect on Huntington's disease under the microscope
Knowledge-focused CompletedThis study looked at whether drinking caffeine is linked to how Huntington's disease progresses in people who have the gene but do not yet show symptoms. Researchers followed 77 adults for several years, measuring brain changes and thinking skills. The goal was to learn if caffei…
Matched conditions: HUNTINGTON DISEASE
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated May 26, 2026 02:56 UTC
-
Brain energy levels tracked in huntington study
Knowledge-focused CompletedThis study looked at how brain energy levels change as Huntington disease progresses. Researchers used a special type of MRI to measure energy-related chemicals in the brains of 50 adults with Huntington disease. No treatment was given; the goal was simply to understand the disea…
Matched conditions: HUNTINGTON DISEASE
Phase: NA • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated May 22, 2026 13:50 UTC
-
New Huntington's drug tested for safety in small trial
Knowledge-focused CompletedThis early-stage study tested the safety and tolerability of an experimental drug called SAGE-718 in 6 people: healthy adults and patients with Huntington's disease. The main goal was to check for side effects and how the drug moves through the body. It was a Phase 1 trial, meani…
Matched conditions: HUNTINGTON DISEASE
Phase: PHASE1 • Sponsor: Supernus Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated May 18, 2026 12:10 UTC
-
HD families share thoughts on research in new survey
Knowledge-focused CompletedThis completed study surveyed 131 people affected by Huntington's disease (HD) to learn about their feelings, attitudes, and beliefs toward clinical research. Participants included people with HD or those at risk, aged 18 and older, living in the United States. The goal was to he…
Matched conditions: HUNTINGTON DISEASE
Sponsor: Huntington Study Group • Aim: Knowledge-focused
Last updated May 18, 2026 12:08 UTC
-
Brain energy boost? small study explores huntington treatment
Knowledge-focused CompletedThis study tested whether a treatment could improve brain energy use in people with early Huntington disease. Ten participants had special MRI scans to measure brain metabolism. The goal was to see if the treatment could help brain cells work better and slow the disease.
Matched conditions: HUNTINGTON DISEASE
Phase: PHASE2 • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC